| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 9 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Australia | 5 | |
| #4 | Canada | 4 | |
| #5 | United States | 4 | |
| #6 | China | 3 | |
| #7 | Japan | 3 | |
| #8 | Israel | 2 | |
| #9 | South Africa | 2 | |
| #10 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Analysing materials | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pfleger Kevin Donald George | 24 |
| #2 | Williams James | 18 |
| #3 | Mccall Elizabeth | 18 |
| #4 | Seeber Ruth Marie | 16 |
| #5 | Eidne Karin Ann | 12 |
| #6 | See Heng Boon | 12 |
| #7 | Dalrymple Matthew Blake | 7 |
| #8 | Pfleger Kevin | 5 |
| #9 | James Williams | 4 |
| #10 | Elizabeth Mccall | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021056051A1 | Method and composition for the treatment of disease | |
| CA2821985A1 | Combination therapy | |
| WO2010129987A1 | Novel receptor hetero-dimers/-oligomers | |
| CA2756743A1 | Novel receptor hetero-dimers/-oligomers | |
| WO2010031114A1 | Novel receptor hetero-dimers/-oligomers | |
| WO2010003170A1 | Novel receptor hetero-dimers/-oligomers | |
| AU2009257174A1 | Novel receptor hetero-dimers/-oligomers | |
| AU2007317204A1 | Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |